home · filing · 0000078003-24-000127
8-K
filed July 1, 2024, 7:59 PM ET
ticker PFE
CIK 0000078003
leadership
confidence high
sentiment neutral
materiality 0.30
Cyrus Taraporevala elected to Pfizer's Board of Directors effective June 27, 2024
PFIZER INC
Taraporevala, former President & CEO of State Street Global Advisors (2017-2022), joins Board.
Appointed to Audit Committee and Compensation Committee immediately.
Also serves on boards of Shell plc and Bridgepoint Group plc.
Background includes roles at Fidelity, BNY Mellon, Legg Mason, Citigroup, and McKinsey.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Cyrus Taraporevala
Director
Effective 2024-06-27
Filed July 1, 2024, 7:59 PM ET
elected Cyrus Taraporevala to serve as a member of the Company’s Board, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Cyrus Taraporevala was elected as Director at PFIZER INC.
Action elected
Role Director
Exact text from the filing
elected Cyrus Taraporevala to serve as a member of the Company’s Board, effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0000078003-24-000127
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.